StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3026% below fair value
$7.01−0.30 (-4.10%)

Close on Nov 19, 2026Market cap $132.04MP/E 29.2Yield –

OptimizeRx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

OptimizeRx's free cash flow for the twelve months ending Jun 30, 2026 was $18.36M, up 77.5% year over year. For fiscal 2025 it was $18.66M, up 290.6% from the year before. Over ten years it grew 43.2% a year on average. The highest annual figure on record is $18.66M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.66M+290.6%
FY2024Dec 31, 2024$4.78M–
FY2023Dec 31, 2023-$7.33M-169.3%
FY2022Dec 31, 2022$10.57M+1589.8%
FY2021Dec 31, 2021$625.72K–
FY2020Dec 31, 2020-$6.38M–
FY2019Dec 31, 2019-$1.75M-330.6%
FY2018Dec 31, 2018$758.19K–
FY2017Dec 31, 2017-$1.52M–
FY2016Dec 31, 2016-$644.40K-225.6%
FY2015Dec 31, 2015$513.06K–
FY2014Dec 31, 2014-$63.33K-105.6%
FY2013Dec 31, 2013$1.13M–
FY2012Dec 31, 2012-$626.26K–
FY2011Dec 31, 2011-$534.61K–
FY2010Dec 31, 2010-$1.31M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.58M+88.4%
Q1 FY2026Mar 31, 2026-$488.00K-112.7%
Q4 FY2025Dec 31, 2025$7.08M+3809.9%
Q3 FY2025Sep 30, 2025$3.19M+80.0%
Q2 FY2025Jun 30, 2025$4.55M+517.5%
Q1 FY2025Mar 31, 2025$3.84M+83.9%
Q4 FY2024Dec 31, 2024$181.00K–
Q3 FY2024Sep 30, 2024$1.77M+23.2%
Q2 FY2024Jun 30, 2024$737.00K–
Q1 FY2024Mar 31, 2024$2.09M–
Q4 FY2023Dec 31, 2023-$6.26M-324.7%
Q3 FY2023Sep 30, 2023$1.44M-64.6%
Q2 FY2023Jun 30, 2023-$2.39M–
Q1 FY2023Mar 31, 2023-$114.58K-161.6%
Q4 FY2022Dec 31, 2022$2.79M+1577.8%
Q1 FY2022Mar 31, 2022$4.07M+147.0%
Q4 FY2021Dec 31, 2021-$1.37M–
Q3 FY2021Sep 30, 2021$186.02K–
Q2 FY2021Jun 30, 2021$166.12K+40.1%
Q1 FY2021Mar 31, 2021$1.65M–
Q4 FY2020Dec 31, 2020-$2.62M–
Q3 FY2020Sep 30, 2020-$126.85K-114.5%
Q2 FY2020Jun 30, 2020$118.58K-87.1%
Q1 FY2020Mar 31, 2020-$3.75M-451.5%
Q2 FY2019Jun 30, 2019-$115.66K–
Q1 FY2019Mar 31, 2019$876.12K–
Q4 FY2018Dec 31, 2018$921.53K–
Q3 FY2018Sep 30, 2018$1.07M–
Q2 FY2018Jun 30, 2018-$440.26K–
Q1 FY2018Mar 31, 2018-$791.19K–
Q4 FY2017Dec 31, 2017-$7.72K–
Q3 FY2017Sep 30, 2017-$793.66K-1395.8%
Q2 FY2017Jun 30, 2017-$407.31K-493.9%
Q1 FY2017Mar 31, 2017-$313.38K–
Q4 FY2016Dec 31, 2016-$508.46K–
Q3 FY2016Sep 30, 2016$61.25K–
Q2 FY2016Jun 30, 2016$103.41K–
Q1 FY2016Mar 31, 2016-$300.59K–

More OptimizeRx figures

See a number that looks wrong?